Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 2611 of 6372
-
Survivor-Made messages aim to increase HIV testing and overdose kit use
Knowledge-focused Not yet recruitingThis project will assess whether a digital survivor crowdsourced intervention can increase HIV/STI/HCV testing and overdose prevention kit utilization among survivors of sex trafficking living in New York City. Survivors of sex trafficking have among the highest rates of HIV/STIs…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Lifestyle makeover may slow early myeloma
Disease control Not yet recruitingA prospective, pilot study to assess the impact of a 12-month multi-focal lifestyle intervention on myeloma-relevant biomarkers in patients with MGUS or SM. The multimodal lifestyle intervention has six foci that patients will participate in over the course of one-year.
Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New online tool aims to ease prostate cancer treatment choices
Symptom relief Not yet recruitingThis study will test a web-based supportive care program called the Support, Communication, and Information Program for Prostate Cancer - Interactive (SCIPI). SCIPI provides men with localized prostate cancer and their families with easy-to-understand information, tools to prepar…
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
School lunch makeover: can Co-Created menus curb teen obesity?
Prevention Not yet recruitingThe goal of this clinical trial is to learn if a multicomponent nutrition program developed together with the students, parents, teachers and canteen operators will improve nutrition status of adolescents. It will also learn about the acceptability and feasibility of implementing…
Sponsor: Norwegian University of Science and Technology • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Can a bladder drug rev up metabolism and fight aging?
Disease control Not yet recruitingThis 12-week randomized, double-blind, placebo-controlled trial will test the hypothesis that Vibegron (brand name GEMTESA) can improve energy metabolism, cardiometabolic risk factors, and physical and cognitive function in middle-aged and older adults with obesity.
Phase 3 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can mindfulness ease migraine in teens? new study aims to find out
Symptom relief Not yet recruitingThe goal of this study (supported by and included in the NIH HEAL Initiative: https://heal.nih.gov/) is to learn if a fully virtual study comparing two telehealth group interventions for adolescents with migraine is feasible and acceptable: 1. Telehealth group mindfulness-based …
Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
New graft aims to make dialysis easier for kidney patients
Disease control Not yet recruitingThis is a multi-site, single-blind with parallel group, randomized controlled trial of Healionics STARgraft (10401) vascular graft for hemodialysis access compared with a market-leading commercially available ePTFE vascular graft (Gore Propaten Vascular Graft).
Sponsor: Healionics Corporation • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
One conversation after childbirth could cut trauma risk
Symptom relief Not yet recruitingAdverse or unexpected obstetric events can negatively affect women's psychological well-being and childbirth experience, increasing the risk of postpartum traumatic stress. However, structured postnatal debriefing is not routinely implemented in clinical practice, and evidence re…
Sponsor: Parc de Salut Mar • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Smart brain pacemaker aims to stop seizures while you sleep
Disease control Not yet recruitingThe goal of this clinical trial is to explore a new type of personalized brain stimulation that works during day time and night time hours using the Medtronic Percept Deep Brain Stimulation (DBS) device in patients with Lennox-Gastaut Syndrome. The main question(s) this study aim…
Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New nerve block technique aims to protect breathing in elderly shoulder surgery patients
Symptom relief CancelledBackground: Proximal humeral fractures are common in elderly patients and often require surgical fixation (open reduction and internal fixation). Traditional regional anesthesia techniques, such as the interscalene brachial plexus block, may provide incomplete pain relief in the …
Sponsor: Shanghai Tong Ren Hospital • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New ointment could tame HHT nosebleeds
Symptom relief Not yet recruitingPeople with hereditary hemorrhagic telangiectasia (HHT) often experience frequent and severe nosebleeds that can disrupt daily life and lead to anemia, medical procedures, and reduced quality of life. This study is testing a new nasal ointment called TOR-582, which contains sirol…
Phase 1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Can a Parent's lap tame dental fear in toddlers?
Symptom relief Not yet recruitingThe goal of this study is to learn if a modified bottom-to-bottom comfort position is a feasible alternative to the traditional knee-to-knee position during dental hygiene examinations for patients aged 12 months to 5 years. In the modified position, the patient sits in their car…
Sponsor: Children's Hospital Colorado • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Magic mushroom study seeks to unlock Brain's mood secrets
Knowledge-focused Recruiting nowTwenty healthy adults (≥21 years old) will be enrolled to evaluate the efficacy of a single oral dose of psilocybin (25 mg) administered with or without pretreatment using oral pimavanserin (34 mg) or placebo. Outcome assessments will occur at 1 week and 1 month following psilocy…
Phase 1/2 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Can a Zirconia-Enriched filling outlast standard materials for Kids' cavities?
Disease control Not yet recruitingClinical trial comparing two tooth-colored restorative materials for treating cavities between the teeth of primary molars in children aged 4 to 7 years. The study will compare zirconia-fortified glass ionomer (Zirconomer-P) with resin-modified glass ionomer (RMGI) to evaluate th…
Sponsor: Cairo University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can cannabis curb opioid cravings? new study aims to find out
Knowledge-focused Not yet recruitingThe study will enroll participants with opioid use disorder and participants will reside at the University of Kentucky Hospital for this 6-week inpatient trial. During this time, double-blind doses of cannabis and opioids will be administered. The goal of the project is to determ…
Phase 1 • Sponsor: Shanna Babalonis, PhD • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
New knee pain block could get you walking faster after surgery
Symptom relief Not yet recruitingOver the last two decades, perioperative analgesia has evolved. Spinal and epidural anaesthesia, once common, have been gradually phased out due to their side effects. The femoral block combined with the sciatic block, possibly with a perineural catheter, is now the gold standard…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could a common supplement ease long COVID in teens?
Symptom relief Not yet recruitingThe COVID-19 pandemic has swept across the globe, affecting millions of individuals with varying degrees of severity. While many individuals recover from the acute phase of the infection, a significant proportion continue to experience persistent and debilitating symptoms long af…
Phase 1/2 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could a daily cup of green tea extract ease cancer nerve pain?
Symptom relief Not yet recruitingThe overall objective of this study is to test an intervention of green tea extract (GTE) to mitigate neuropathic pain in patients, specifically cancer survivors, receiving supportive palliative care. The central hypothesis is that daily, oral, encapsulated GTE will mitigate neur…
Phase 1 • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Nutritional boost before colorectal surgery may cut complications
Disease control Not yet recruitingThis study aims to explore the effectiveness of perioperative Oral Nutritional Supplementation (ONS) combined with an optimized, tailored diet in reducing the risk of postoperative complications and improving the nutritional status of colorectal cancer patients scheduled for cura…
Sponsor: Istituto Clinico Humanitas • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can 3D scans reveal the true impact of chin fillers?
Symptom relief Recruiting nowThe goal of this prospective study is to analyze volumetric changes in the lower face after hyaluronic acid filler injections over 90 days. The primary aim of the study is to quantify volume change of the lower face rea over time after injection of filler. The secondary aim is t…
Phase 4 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC